Conference Description

Achieving and Maintaining Targets in Diabetes

November 8, 2007
Morton's Steakhouse
213 SW Clay Street
Portland, OR

Tell a friend about this conference

Download the brochure for this conference

CME Credits: 2.0*

Nonrefundable registration fee: $0.

Target Audience: This activity is designed for primary care physicians, internists, family practitioners, nurse practitioners, and physicians assistants who have a high interest in treating patients with diabetes.

Program Summary:

This two-hour CME activity for health care providers treating diabetes will examine the range of therapeutic options available to treat Diabetes Mellitus from oral to injectable and inhaled agents in a very useful and practical fashion. It is intended to be a working dinner meeting, led by a regional thought leader that will allow for effective transmission and integration of knowledge. Attendees will be able to utilize knowledge gained to immediately improve practice patterns. The education goal of this program is to review the current pharmacologic options for treatment of type 2 diabetes, including oral, injectable and inhaled therapies, and refine practice patterns through didactic lecture and small group, case-based discussions.

The first hour will review the treatment paradigms of the American Diabetes Association and the European Association for the Study of Diabetes. Recent trials will be presented to support treatment decisions. By using an algorithmic approach, recommendations for the management of Type 2 Diabetes will be presented. This will examine the various therapies available today, both oral and injectable, and categorize them according to function (i.e. basal, prandial, or mixed). This will allow participants to more easily understand how to apply individual therapies to identified glycemic loads (i.e. fasting hyperglycemia vs post-prandial issues vs both).

The second hour will utilize a more informal roundtable style, case-based discussion to facilitate interaction amongst attendees and enhance knowledge retentin. Several clinical vignettes will be presented to demonstrate material presented with an emphasis on optimal incorporation of insulin therapy. Participants will also have an opportunity to present their own cases at the program, address their individual concerns with the thought leader, and ultimately walk away more confident in their skill set.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. Discuss the early pathogenesis oftype 2 diabetes and its prevention
2. Analyze methods of attaining tight glucose control in a primary care setting
3. Explain the natural progression to relative insulin deficiency in patients with type 2 diabetes
4. identify methods of optimizing glycemic control in patients with type 2 diabetes
5. Explain risks and discuss approaches for minimizing risk of hypoglycemia and weight gain with insulin in patients with type 2 diabetes

Agenda:
Wednesday, November 7, 2007

6:30-7:00 pm		Welcome and Registration
7:00-8:00 pm		Achieving and Maintaining Targets in Diabetes
8:00-9:00 pm		Case-based Discussion, Q and A

Faculty:
Jeffrey E. Hartman, MD
Endocrinologist
Spokane, WA

Course Director: Gregg Sherman, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 2.0 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this continuing medical education activity for a maximum of 2.0 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This offering meets the requirements for 2.0 contact hours for nurses, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through an educational grant from Novo Nordisk.

REGISTRATION FOR THIS PROGRAM IS CLOSED.